MoUs signed with pioneers

6 February 2018

Cronin Group Plc

("Cronin Group" or the "Company")

MoUs signed with first pioneers

Two leading international life science reagent and chemicals manufacturers to become the first to agree to join the Company's Pioneer Programme, evaluating the DigitalGlassware™platform

Cronin Group, the AIM listed company focusing on digitizing chemistry, announces that it has entered into Memoranda of Understanding ("MoUs") with two leading international life science reagent and chemicals manufacturers; one, a US headquartered business, with laboratory operations worldwide and the other, a UK based subsidiary of a NASDAQ listed company. The MOUs set out the principal terms for a formal evaluation by the two companies of the Company's DigitalGlassware™ platform.

The DigitalGlassware™ platform, comprising a powerful and easy-to-use software interface with a unique, low footprint sensor array, collects, stores and processes data generated from chemical experiments and allows access to reproducible chemistry via internet protocols. Data analysis need not just be performed retrospectively, but in real-time and a-priori, delivering back to the users, data which when combined with artificial intelligence and machine learning technologies, has the potential to dramatically increase reproducibility and provide unique insights.

Cronin Group has identified a select number of leading companies and institutions involved in the field of chemistry to participate in its Pioneer Programme. The purpose of the programme is to trial the Company's technology with the full range of target users, allowing the Company to observe its performance in different operating environments and locations worldwide. These observations will contribute towards future technology optimisation, prior to wider dissemination to target users. The Pioneer companies will also assess the performance of the DigitalGlassware™ platform, specifically to understand how it can help improve the outcomes of chemical processes, including precision and reproducibility, with an eye to how the technology can help in discovering/enabling new synthetic routes and chemical entities.

Mark Warne, Executive Chairman of Cronin Group, commented: "We are delighted to be entering into beta stage deployment with such knowledgeable industry innovators as the initial pioneers announced today. Their help will be invaluable in supporting us in shaping the DigitalGlassware™ platform for broader adoption across our target user groups as we seek to build awareness and understanding of the product and our long-term vision for the digitization of chemistry."

For further information: